STOCK TITAN

Director Bohjalian at Healthcare Realty (NYSE: HR) receives 6,683-share equity grant

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Healthcare Realty Trust Inc director Thomas N. Bohjalian reported a compensation-related grant of common stock. He received 6,683 shares of common stock on May 19, 2026 at a value of $20.20 per share, classified as a “Grant, award, or other acquisition.”

After this non-derivative acquisition, Bohjalian directly owns 92,203 shares of Healthcare Realty Trust Inc common stock. The filing reflects an increase in his equity stake through an award rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Bohjalian Thomas N
Role null
Type Security Shares Price Value
Grant/Award Common Stock 6,683 $20.20 $135K
Holdings After Transaction: Common Stock — 92,203 shares (Direct, null)
Footnotes (1)
Shares granted 6,683 shares Non-derivative grant on May 19, 2026
Grant price per share $20.20/share Value used for the common stock award
Shares owned after grant 92,203 shares Direct common stock holdings post-transaction
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Common Stock financial
"security_title: "Common Stock" in the reported transaction"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
non-derivative financial
"transaction_type: "non-derivative" for the stock grant"
Form 4 regulatory
"INSIDER FILING DATA (Form 4): transaction for Thomas N. Bohjalian"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bohjalian Thomas N

(Last)(First)(Middle)
3310 WEST END AVENUE, SUITE 700
ATTENTION: ANDREW LOOPE

(Street)
NASHVILLE TENNESSEE 37203

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Healthcare Realty Trust Inc [ HR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/19/2026A6,683A$20.292,203D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Andrew E. Loope as power of attorney05/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Healthcare Realty Trust (HR) report for Thomas N. Bohjalian?

Healthcare Realty Trust director Thomas N. Bohjalian received a grant of 6,683 shares of common stock. The transaction was recorded as a non-derivative “Grant, award, or other acquisition” rather than an open-market trade, increasing his directly held ownership stake.

At what price was the Healthcare Realty Trust (HR) share grant to Thomas N. Bohjalian recorded?

The 6,683-share grant to Thomas N. Bohjalian was recorded at $20.20 per share. This value reflects the per-share price used for the award in the Form 4 and helps investors understand the implied size of the equity-based compensation.

How many Healthcare Realty Trust (HR) shares does Thomas N. Bohjalian own after this transaction?

Following the stock grant, Thomas N. Bohjalian directly owns 92,203 shares of Healthcare Realty Trust common stock. This total, reported in the Form 4, represents his post-transaction holdings after adding the 6,683-share compensation-related award.

Was the Healthcare Realty Trust (HR) transaction by Thomas N. Bohjalian a purchase or a grant?

The transaction was a grant, not an open-market purchase or sale. It is coded “A” on the Form 4, meaning “Grant, award, or other acquisition,” indicating equity compensation rather than a discretionary market trade in Healthcare Realty Trust shares.

Does the Form 4 for Healthcare Realty Trust (HR) show any stock sales by Thomas N. Bohjalian?

No sales are reported in this Form 4 for Thomas N. Bohjalian. The filing shows only one non-derivative acquisition coded as a grant of 6,683 shares, with no dispositions, exercises, gifts, or tax-withholding transactions disclosed in the summarized data.